title: Reoperations on heart valve prostheses: an analysis of operative risks and late results.
abstract: To evaluate risks and complications of reoperations on heart valve prostheses, we reviewed data on 183 patients who underwent reoperation because of prosthetic valve malfunction. The incremental effect of the redo procedure on hospital mortality and morbidity was studied by comparing primary and reoperative procedures and analyzing a series of possible predisposing factors. Late survival after first and second reoperations was computed, and possible determinants of late mortality were examined. Overall operative mortality was 8.7%; emergency operation (p = 0.0001), previous thromboembolism (p = 0.05), and advanced New York Heart Association functional class (p = 0.031) were the independent determinants. In a series of 1,355 patients having primary or secondary isolated valve replacement, the redo procedure was a significant risk factor in the univariate analysis (p = 0.025) but not in the multivariate analysis except for the subset of patients having mitral valve replacement (p = 0.052). The postoperative course was quite complicated, as evidenced by the long mean stay in the intensive care unit (mean stay, 3.8 days; longer than 2 days for 26% of the survivors). Nevertheless, postoperative complications were not significantly greater after a redo procedure than after a primary operation. Actuarial survival at 7 years was 57.3% +/- 8%. A comparison with a nonhomogeneous series from our institution did not demonstrate significant differences. In the subset of 16 patients having a second reoperation, late survival was 37.8% +/- 16% at 2 years. Advanced New York Heart Association class (p = 0.0001), double prosthetic valve dysfunction (p = 0.003), and any indication other than primary tissue failure (p = 0.06) were determinants of late mortality.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Cardiac Surgery, University of Torino, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Pansini
authors.forename: G
authors.initials: G
authors.lastname: Ottino
authors.forename: P G
authors.initials: PG
authors.lastname: Forsennati
authors.forename: G
authors.initials: G
authors.lastname: Serpieri
authors.forename: G
authors.initials: G
authors.lastname: Zattera
authors.forename: R
authors.initials: R
authors.lastname: Casabona
authors.forename: M
authors.initials: M
authors.lastname: di Summa
authors.forename: M
authors.initials: M
authors.lastname: Villani
authors.forename: G A
authors.initials: GA
authors.lastname: Poletti
authors.forename: M
authors.initials: M
authors.lastname: Morea
mesh_terms: D001705:Bioprosthesis; D005260:Female; D006350:Heart Valve Prosthesis / Q000401:mortality / Q000706:statistics & numerical data; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011183:Postoperative Complications / Q000453:epidemiology*; D011475:Prosthesis Failure; D012086:Reoperation / Q000401:mortality / Q000706:statistics & numerical data; D012307:Risk Factors; D013503:Surgery Department, Hospital / Q000706:statistics & numerical data*; D015996:Survival Rate